EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY-NC-ND 4.0

Endogenous Levels, Detection Time, and Symptoms of Gamma‐Hydroxybutyric Acid: Results From a Placebo‐Controlled Clinical Trial

Kathrine Bohn Faldborg iD, Lambert Kristiansen Sørensen iD, Jørgen Bo Hasselstrøm iD, Charlotte Uggerhøj Andersen iD

Basic & Clinical Pharmacology & Toxicology · 2025-12 · 137 (6)

DOI: 10.1111/bcpt.70133 ↗

At a glance

Randomisierte kontrollierte Studie in Basic & Clinical Pharmacology & Toxicology, published online on 2025-11-08. Written by Kathrine Bohn Faldborg and 3 co-authors. Institution: Department of Forensic Medicine, Aarhus University, Aarhus, Denmark. Major MEDLINE topics: Sodium Oxybate, Hydroxybutyrates, Substance Abuse Detection. Cited 2 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: The Council of the Danish Victims Fund.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Gamma‐hydroxybutyric acid (GHB), a potential agent in drug‐facilitated sexual assault, is difficult to detect due to rapid elimination, endogenous presence, and possible postsampling formation. We conducted a randomised, placebo‐controlled trial in 30 healthy volunteers, administering 50‐mg/kg sodium oxybate or placebo, to investigate symptoms, pharmacokinetics and endogenous concentrations. Blood was collected in fluoride‐oxalate (FX) tubes, and urine and oral fluid in additive‐free tubes, at baseline, 1, 2, 3, 4, 6, 12, and 24 (urine only) hours post‐administration. Samples were immediately cooled, stored at −70°C, and analysed using LC–MS/MS. Maximal endogenous GHB concentrations were 0.050 μg/mL in blood, 0.41 μg/mL in urine, and 0.93 μg/mL in oral fluid. GHB‐treated participants reported vertigo and fatigue, with no significant memory impairment. Median peak GHB concentrations post‐administration were 50, 440, and 29 μg/mL in blood, urine, and oral fluid, respectively. Oral fluid appeared unsuitable for GHB detection. As endogenous concentrations in blood did not exceed 0.050 μg/mL, a theoretical cut‐off with a safety margin (0.25 μg/mL) would yield a negligible risk of false positives in samples collected in FX tubes and cooled immediately. Applying this cut‐off extended the blood detection window ≥ 2 h in all GHB‐treated participants, surpassing that in urine at a 6‐μg/mL cut‐off.

Subjects

MeSH terms (MEDLINE)

Sodium OxybateHydroxybutyratesSubstance Abuse DetectionHumansMaleAdultFemaleYoung AdultSalivaHealthy VolunteersTandem Mass SpectrometryDouble-Blind MethodChromatography, LiquidTime FactorsMiddle Aged

Author keywords

GHBdetection windowdrug‐facilitated sexual assaultforensic toxicologygamma‐hydroxybutyrate

Substances

Sodium OxybateHydroxybutyrates4-hydroxybutyric acid

Authors and institutions

  • Department of Forensic Medicine, Aarhus University, Aarhus, Denmark.
  • Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark.

ORCID profiles: Kathrine Bohn Faldborg, Lambert Kristiansen Sørensen, Jørgen Bo Hasselstrøm, Charlotte Uggerhøj Andersen

Funding

  • The Council of the Danish Victims Fund

Cite

APA

Faldborg, K. B., Sørensen, L. K., Hasselstrøm, J. B., & Andersen, C. U. (2025). Endogenous Levels, Detection Time, and Symptoms of Gamma‐Hydroxybutyric Acid: Results From a Placebo‐Controlled Clinical Trial. Basic & Clinical Pharmacology & Toxicology, 137(6). https://doi.org/10.1111/bcpt.70133

Vancouver

Faldborg KB, Sørensen LK, Hasselstrøm JB, Andersen CU. Endogenous Levels, Detection Time, and Symptoms of Gamma‐Hydroxybutyric Acid: Results From a Placebo‐Controlled Clinical Trial. Basic & Clinical Pharmacology & Toxicology. 2025;137(6). doi:10.1111/bcpt.70133

BibTeX
@article{Faldborg2025,
  author = {Faldborg, Kathrine Bohn and Sørensen, Lambert Kristiansen and Hasselstrøm, Jørgen Bo and Andersen, Charlotte Uggerhøj},
  title = {Endogenous Levels, Detection Time, and Symptoms of Gamma‐Hydroxybutyric Acid: Results From a Placebo‐Controlled Clinical Trial},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2025},
  volume = {137},
  number = {6},
  doi = {10.1111/bcpt.70133}
}
Start for free →